- From: Bevil, Mike <mike_bevil@merck.com>
- Date: Wed, 27 Jun 2007 08:08:40 -0400
- To: "Alan Ruttenberg" <alanruttenberg@gmail.com>, "public-semweb-lifesci hcls" <public-semweb-lifesci@w3.org>
Alan, I would be interested in collaborating with you on this. Please feel free to contact me directly and we can discuss. Best Regards, Mike Bevil Manager, Web and Database Technology Innovation Merck Research Laboratories Research Information Services 770 Sumneytown Pike, West Point, PA 19486 telephone: 215.652.2134 interoffice: WP1-9 1157 email: mike_bevil@merck.com -----Original Message----- From: public-semweb-lifesci-request@w3.org [mailto:public-semweb-lifesci-request@w3.org] On Behalf Of Alan Ruttenberg Sent: Wednesday, June 27, 2007 1:56 AM To: public-semweb-lifesci hcls Subject: Any takers for reviewing and presenting to group evaluation of open source drug database? The DrugDB database, http://www.e-mds.com/solutions/drug_database/ drugdb.html is open source, and I have applied and received access to it. The initial format is Microsoft SQL Server backup file, and Colin Knep from the Alzforum has kindly converted it to MySQL, so it can either be loaded into MySQL or parsed as text (lots of SQL inserts). The goal of the evaluation is to review the contents of the database and the data model and present it to the group (or find adequate existing documentation on this), as a preliminary to evaluating whether we should convert it into RDF. Someone familiar with what is available in current drug databases and able to assess the quality and thoroughness of the contents would be very helpful in this effort. Let me know if you are interested, and I can give access to the files (assuming you accept the terms of the license) Best, Alan ------------------------------------------------------------------------------ Notice: This e-mail message, together with any attachments, contains information of Merck & Co., Inc. (One Merck Drive, Whitehouse Station, New Jersey, USA 08889), and/or its affiliates (which may be known outside the United States as Merck Frosst, Merck Sharp & Dohme or MSD and in Japan, as Banyu - direct contact information for affiliates is available at http://www.merck.com/contact/contacts.html) that may be confidential, proprietary copyrighted and/or legally privileged. It is intended solely for the use of the individual or entity named on this message. If you are not the intended recipient, and have received this message in error, please notify us immediately by reply e-mail and then delete it from your system. ------------------------------------------------------------------------------
Received on Wednesday, 27 June 2007 12:09:22 UTC